TLR4 and influenza: GLA-AF, an emulsion-free aqueous formulation with glucopyranosyl lipid adjuvant, a TLR-4 agonist, has been evaluated for ID immunization with an H5-VLP influenza vaccine and showed low skin reactogenicity in guinea pigs and stimulated strong anti-H5 responses in C57BL/6 mice [33].